Prof. Dr. Stefan Kaehler
Angestellt, Exec Dir Qualified Person for Pharmacovigilance EU & UK, Bristol Myers Squibb
Wien, Österreich
Werdegang
Berufserfahrung von Stefan Kaehler
Bis heute 2 Jahre und 8 Monate, seit Okt. 2021
Exec Dir Qualified Person for Pharmacovigilance EU & UK
Bristol Myers Squibb
2 Jahre und 6 Monate, Apr. 2019 - Sep. 2021
Exec. Dir. II, Global Drug Safety & Risk Management, EEA-QPPV, GMP-QP
Celgene International
Serve as EEA QPPV, QPPV ARAB Region, QP Batch Release (all pharmaceutical forms including ATMPs marketed or clinical trial supply), Head Pharmacovigilance EU Big 5 & CEE Region (Czech Republic, Slovenia, Slovakia, Hungary, Poland, Estonia, Latvia, Lithuania, Serbia, FYROM…) and other EEA countries via matrix Lead. QPPV for ARAB-Region on behalf of Celgene Int Sarl. Responsible for total Budget and Workforce (FTE
11 Monate, Mai 2018 - März 2019
Exec. Dir., Global Drug Safety & Risk Management International, EEA-QPPV, GMP-QP
Celgene International
Serve as EEA QPPV, QPPV ARAB Region, QP Batch Release (all pharmaceutical forms including ATMPs marketed or clinical trial supply), Head Pharmacovigilance EU Big 5 & CEE Region (Czech Republic, Slovenia, Slovakia, Hungary, Poland, Estonia, Latvia, Lithuania, Serbia, FYROM…). QPPV for ARAB-Region on behalf of Celgene Int Sarl. Responsible for total Budget and Workforce (FTE)
11 Monate, Juni 2017 - Apr. 2018
Exec. Dir, Global Drug Safety & Risk Management International, EEA-QPPV, GMP-QP
Celgene International
Serve as EEA QPPV, QPPV ARAB Region, QP Batch Release (all pharmaceutical forms including ATMPs marketed or clinical trial supply), Functional Lead and Manager for EU big 5 Drug Safety Managers & CEE Region (Czech Republic, Slovenia, Slovakia, Hungary and Poland). QPPV for ARAB-Region on behalf of Celgene Int Sarl. Responsible for total Budget and Workforce (FTE) as Matrix Lead. Global Lead Safety Physician CAR T Cells ad interim (Jan 2018 to Mai 2018)
1 Jahr und 3 Monate, März 2016 - Mai 2017
Executive Director, Global Senior Lead Safety Scientist (CAR T cells) & EEA-QPPV
Celgene International
Executive Director Global Lead Safety Physician/Scientist CAR T Cells, Global Business Development & Alliances, Global Drug Safety & Risk Management, EEA-QPPV, GMP-QP-Celgene Austria Drive safety science oversight and execution of Global Drug Safety and Risk Management Strategy including Business Alliances for all new Celgene compounds, Lead Safety Physician/Scientist responsible for CAR-T cells (i.e CD19 constructs) clinical development & Safety & Risk Management, serve as EEA QPPV and QP Batch Release
7 Monate, Aug. 2015 - Feb. 2016
Senior Director Global Risk Management Standards & GMP-QP EEA
Celgene Europe Ltd, London, UK
1 Jahr und 1 Monat, Aug. 2014 - Aug. 2015
Senior Director Global Risk Management Standards & EEA-QPPV; GMP-QP
Celgene Europe Ltd.
1 Jahr und 4 Monate, Mai 2013 - Aug. 2014
Director Global Risk Management and QPPV, QP-Batch Release
Celgene Europe Ltd
Global Drug Safety & Risk Management
2 Monate, Apr. 2013 - Mai 2013
Director Global Risk Management and dQPPV, QP-Batch Release
Celgene Europe Ltd
Global Drug Safety & Risk Management
1 Jahr und 10 Monate, Juni 2011 - März 2013
Associate Director Risk Management Europe & APAC and dQPPV; QP Batch Release
Celgene Europe Ltd.
Global Drug Safety & Risk Management
8 Monate, Nov. 2010 - Juni 2011
Senior Manager Global Risk Management Standards
Celgene Europe Ltd
QPPV-Office Global Drug Safety & Risk Management
2 Jahre und 6 Monate, Mai 2008 - Okt. 2010
Regulatory & Safety Manager, Quality Responsible Person (QP)
Celgene
9 Jahre und 3 Monate, Feb. 1999 - Apr. 2008
Head of Clinical Research, Development, Operations, Datamangement, Biometrics
Gebro Pharma GmbH
Assistent mit Leitung einer Forschungsgruppe, Betreuung von Diplomanden und Doktoranten
Dissertation im Fach Pharmakologie & Toxikologie, Univ. Assistent
Assistent für pharmazeutisch-technologische Übungen, Gruppenleitung
Ausbildung von Stefan Kaehler
1 Monat, März 2016 - März 2016
Pharmakologie & Toxikologie
Universität Innsbruck
Priv. Doz.
1 Monat, Apr. 2011 - Apr. 2011
Leadership & Strategy in Pharmaceuticals and Biotech
Harvard University Business School
4 Jahre und 2 Monate, Okt. 1994 - Nov. 1998
Pharmakologie & Toxikologie
Universität Innsbruck
8 Jahre und 1 Monat, Okt. 1986 - Okt. 1994
Pharmazie
Universität Innsbruck
Pharmazeutische Technologie, Pharmakologie & Toxikologie
Sprachen
Deutsch
Muttersprache
Englisch
Fließend
Spanisch
Grundlagen